Russell, E.S. Hereditary anemias of the mouse: a review for geneticists. Adv. Genet. 20, 357–459 (1979).
Goldwasser, E. Erythropoietin and its mode of action. Blood Cells 10, 147–162 (1984).
Zermati, Y. et al. Caspase activation is required for terminal erythroid differentiation. J. Exp. Med. 193, 247–254 (2001).
Ribeil, J.A. et al. Hsp70 regulates erythropoiesis by preventing caspase-3-mediated cleavage of GATA-1. Nature 445, 102–105 (2007).
Koury, M.J. & Bondurant, M.C. Erythropoietin retards DNA breakdown and prevents programmed death in erythroid progenitor cells. Science 248, 378–381 (1990).
Kelley, L.L. et al. Survival or death of individual proerythroblasts results from differing erythropoietin sensitivities: a mechanism for controlled rates of erythrocyte production. Blood 82, 2340–2352 (1993).
Levy, J.E., Jin, O., Fujiwara, Y., Kuo, F. & Andrews, N.C. Transferrin receptor is necessary for development of erythrocytes and the nervous system. Nat. Genet. 21, 396–399 (1999).
Lebrón, J.A. et al. Crystal structure of the hemochromatosis protein HFE and characterization of its interaction with transferrin receptor. Cell 93, 111–123 (1998).
Radoshitzky, S.R. et al. Transferrin receptor 1 is a cellular receptor for New World haemorrhagic fever arenaviruses. Nature 446, 92–96 (2007).
Schmidt, P.J., Toran, P.T., Giannetti, A.M., Bjorkman, P.J. & Andrews, N.C. The transferrin receptor modulates Hfe-dependent regulation of hepcidin expression. Cell Metab. 7, 205–214 (2008).
Moura, I.C. et al. Identification of the transferrin receptor as a novel immunoglobulin (Ig)A1 receptor and its enhanced expression on mesangial cells in IgA nephropathy. J. Exp. Med. 194, 417–425 (2001).
Matysiak-Budnik, T. et al. Secretory IgA mediates retrotranscytosis of intact gliadin peptides via the transferrin receptor in celiac disease. J. Exp. Med. 205, 143–154 (2008).
Woof, J.M. & Mestecky, J. Mucosal immunoglobulins. Immunol. Rev. 206, 64–82 (2005).
Monteiro, R.C. & Van De Winkel, J.G. IgA Fc receptors. Annu. Rev. Immunol. 21, 177–204 (2003).
Moura, I.C. et al. A neutralizing monoclonal antibody (mAb A24) directed against the transferrin receptor induces apoptosis of tumor T lymphocytes from ATL patients. Blood 103, 1838–1845 (2004).
Jacob, C.M., Pastorino, A.C., Fahl, K., Carneiro-Sampaio, M. & Monteiro, R.C. Autoimmunity in IgA deficiency: revisiting the role of IgA as a silent housekeeper. J. Clin. Immunol. 28 (Suppl 1), S56–S61 (2008).
Moura, I.C. et al. Glycosylation and size of IgA1 are essential for interaction with mesangial transferrin receptor in IgA nephropathy. J. Am. Soc. Nephrol. 15, 622–634 (2004).
Duchez, S. et al. Premature replacement of mu with alpha immunoglobulin chains impairs lymphopoiesis and mucosal homing but promotes plasma cell maturation. Proc. Natl. Acad. Sci. USA 107, 3064–3069 (2010).
Erlandsson, L. et al. Joining chain-expressing and -nonexpressing B cell populations in the mouse. J. Exp. Med. 194, 557–570 (2001).
Mestecky, J., Lue, C. & Russell, M.W. Selective transport of IgA. Cellular and molecular aspects. Gastroenterol. Clin. North Am. 20, 441–471 (1991).
De Maria, R. et al. Apoptotic role of Fas/Fas ligand system in the regulation of erythropoiesis. Blood 93, 796–803 (1999).
Suzuki, M. et al. Real-time monitoring of stress erythropoiesis in vivo using Gata1 and β-globin LCR luciferase transgenic mice. Blood 108, 726–733 (2006).
Koury, M.J. Erythropoietin: the story of hypoxia and a finely regulated hematopoietic hormone. Exp. Hematol. 33, 1263–1270 (2005).
Bozzini, C.E. et al. The biology of stress erythropoiesis and erythropoietin production. Ann. N. Y. Acad. Sci. 718, 83–(1994).
Socolovsky, M. Molecular insights into stress erythropoiesis. Curr. Opin. Hematol. 14, 215–224 (2007).
Fossati-Jimack, L. et al. High pathogenic potential of low-affinity autoantibodies in experimental autoimmune hemolytic anemia. J. Exp. Med. 190, 1689–1696 (1999).
Rifai, A., Fadden, K., Morrison, S.L. & Chintalacharuvu, K.R. The N-glycans determine the differential blood clearance and hepatic uptake of human immunoglobulin (Ig)A1 and IgA2 isotypes. J. Exp. Med. 191, 2171–2182 (2000).
Li, H. et al. Transferrin therapy ameliorates disease in β-thalassemic mice. Nat. Med. 16, 177–182 (2010).
Callens, C. et al. Targeting iron homeostasis induces cellular differentiation and synergizes with differentiating agents in acute myeloid leukemia. J. Exp. Med. 207, 731–750 (2010).
Moura, I.C. et al. Engagement of transferrin receptor by polymeric IgA1: evidence for a positive feedback loop involving increased receptor expression and mesangial cell proliferation in IgA nephropathy. J. Am. Soc. Nephrol. 16, 2667–2676 (2005).
Lev, S., Yarden, Y. & Givol, D. Dimerization and activation of the kit receptor by monovalent and bivalent binding of the stem cell factor. J. Biol. Chem. 267, 15970–15977 (1992).
Lev, S., Yarden, Y. & Givol, D. A recombinant ectodomain of the receptor for the stem cell factor (SCF) retains ligand-induced receptor dimerization and antagonizes SCF-stimulated cellular responses. J. Biol. Chem. 267, 10866–10873 (1992).
Miller, B.A. et al. Identification of the erythropoietin receptor domain required for calcium channel activation. J. Biol. Chem. 274, 20465–20472 (1999).
Collawn, J.F. et al. Transferrin receptor internalization sequence YXRF implicates a tight turn as the structural recognition motif for endocytosis. Cell 63, 1061–1072 (1990).
Hirschler-Laszkiewicz, I. et al. TRPC3 activation by erythropoietin is modulated by TRPC6. J. Biol. Chem. 284, 4567–4581 (2009).
Johnson, M.B. & Enns, C.A. Diferric transferrin regulates transferrin receptor 2 protein stability. Blood 104, 4287–4293 (2004).
Huebers, H.A., Josephson, B., Huebers, E., Csiba, E. & Finch, C.A. Occupancy of the iron binding sites of human transferrin. Proc. Natl. Acad. Sci. USA 81, 4326–4330 (1984).
Richardson, D.R. & Ponka, P. The molecular mechanisms of the metabolism and transport of iron in normal and neoplastic cells. Biochim. Biophys. Acta 1331, 1–40 (1997).
Chan, R.Y., Ponka, P. & Schulman, H.M. Transferrin-receptor–independent but iron-dependent proliferation of variant Chinese hamster ovary cells. Exp. Cell Res. 202, 326–336 (1992).
Gutiérrez, L. et al. Ablation of Gata1 in adult mice results in aplastic crisis, revealing its essential role in steady-state and stress erythropoiesis. Blood 111, 4375–4385 (2008).
Li, K., Menon, M.P., Karur, V.G., Hegde, S. & Wojchowski, D.M. Attenuated signaling by a phosphotyrosine-null Epo receptor form in primary erythroid progenitor cells. Blood 102, 3147–3153 (2003).
Arcasoy, M.O. & Jiang, X. Co-operative signalling mechanisms required for erythroid precursor expansion in response to Epo and stem cell factor. Br. J. Haematol. 130, 121–129 (2005).
Perry, J.M., Harandi, O.F. & Paulson, R.F. BMP4, SCF, and hypoxia cooperatively regulate the expansion of murine stress erythroid progenitors. Blood 109, 4494–4502 (2007).
Menon, M.P. et al. Signals for stress erythropoiesis are integrated via an erythropoietin receptor-phosphotyrosine-343-Stat5 axis. J. Clin. Invest. 116, 683–694 (2006).
Harandi, O.F., Hedge, S., Wu, D.C., McKeone, D. & Paulson, R.F. Murine erythroid short-term radioprotection requires a BMP4-dependent, self-renewing population of stress erythroid progenitors. J. Clin. Invest. 120, 4507–4519 (2010).
Auerbach, M. et al. Intravenous iron optimizes the response to recombinant human erythropoietin in cancer patients with chemotherapy-related anemia: a multicenter, open-label, randomized trial. J. Clin. Oncol. 22, 1301–1307 (2004).
Besarab, A. & Coyne, D.W. Iron supplementation to treat anemia in patients with chronic kidney disease. Nat. Rev. Nephrol. 6, 699–710 (2010).
Cook, J.D., Finch, C.A. & Smith, N.J. Evaluation of the iron status of a population. Blood 48, 449–455 (1976).
Keel, S.B. & Abkowitz, J.L. The microcytic red cell and the anemia of inflammation. N. Engl. J. Med. 361, 1904–1906 (2009).
Means, R.T. Jr. & Krantz, S.B. Progress in understanding the pathogenesis of the anemia of chronic disease. Blood 80, 1639–1647 (1992).
Zoller, E.E. et al. Hemophagocytosis causes a consumptive anemia of inflammation. J. Exp. Med. 208, 1203–1214 (2011).
Pasquier, B. et al. Identification of FcαRI as an inhibitory receptor that controls inflammation: dual role of FcRγ ITAM. Immunity 22, 31–42 (2005).
Kerr, M.A. The structure and function of human IgA. Biochem. J. 271, 285–296 (1990).
Meehan, R. et al. Operation Everest II: alterations in the immune system at high altitudes. J. Clin. Immunol. 8, 397–406 (1988).
Bauer, A. et al. The glucocorticoid receptor is required for stress erythropoiesis. Genes Dev. 13, 2996–3002 (1999).
Broudy, V.C., Lin, N.L., Priestley, G.V., Nocka, K. & Wolf, N.S. Interaction of stem cell factor and its receptor c-kit mediates lodgment and acute expansion of hematopoietic cells in the murine spleen. Blood 88, 75–81 (1996).
Lenox, L.E., Perry, J.M. & Paulson, R.F. BMP4 and Madh5 regulate the erythroid response to acute anemia. Blood 105, 2741–2748 (2005).
Falanga, V. et al. Hypoxia upregulates the synthesis of TGF-β 1 by human dermal fibroblasts. J. Invest. Dermatol. 97, 634–637 (1991).
Dullaers, M. et al. A T cell-dependent mechanism for the induction of human mucosal homing immunoglobulin A-secreting plasmablasts. Immunity 30, 120–129 (2009).
Liu, Y. et al. Suppression of Fas-FasL coexpression by erythropoietin mediates erythroblast expansion during the erythropoietic stress response in vivo. Blood 108, 123–133 (2006).